While the World Health Organization (WHO) continues its mission to Wuhan investigating the origin and early transmission...
Gilead Sciences announced on Feb 4, 2021, at the 2021 Asian Pacific Association for the Study of the Liver Con...
ImmVira Group Company, a biotechnology platform dedicated to the development of oncolytic virus(OV) and vector type appr...
Exact Sciences Corp. on 9 Dec 2020 announced that data from the Rx for Positive Node, Endocrine Responsive Breast Cancer...
Hummingbird Bioscience, an innovative clinical-stage biotech company in Singapore and US focused on developing revolutio...
Researchers from the National University of Singapore (NUS) have developed a new way to treat sewage that is much simple...
Japanese firm SUSMED, Inc. has announced that it has received a response from both the Ministers of Health, Labor, ...
France-based Kayentis, a global provider of digital data capture systems for clinical trials, on 2 Dec 2020 announc...
Gilead Sciences, Inc. on 16 Nov 2020 announced the recipients of its first Asia HIV Research Scholar Program. The P...
A joint study by the National Neuroscience Institute (NNI) and Singapore General Hospital (SGH) revealed that patients w...
PPD, Inc., a leading global contract research organization headquartered in the US, is opening a new laboratory in Suzho...
TaiGen Biotechnology Company, Limited ("TaiGen") announced on 5 Oct 2020 that it has filed an Investigational New Drug (...
The Asia-Pacific region is fast emerging as one of the significant regions for clinical trials, with a study by Glo...
Pharma companies around the world are exploring innovative approaches to develop therapeutics and vaccines against COVID...
A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan...
Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc...
Singapore's Concept Medical Inc., focused on vascular intervention drug delivery devices, on 15 Sep 2020 has a...
Taiwan's Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Re...
